$LII

Somasundaram Sivasankaran sold (to issuer) 343 shares of LII

Somasundaram Sivasankaran sold (to issuer) 343 shares of LENNOX INTERNATIONAL INC (LII) on 2026-05-26.

Original reporting
SEC EDGAR · Somasundaram Sivasankaran
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LII
Neutral
low confidence
Mentioned
$LII
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIINeutralLow
01

Why it matters

A director sold 343 shares to the issuer; the filing does not include price or total value and does not cite any company-specific event or guidance change.

02

Market read

This provides incremental positioning information from an insider but lacks fundamental details to justify a high-conviction trading decision.

03

What to watch

No sale price is disclosed and there is no 10b5-1 plan; traders may over-interpret the absence of a plan without knowing the company’s specific mechanics for “sale to issuer” transactions.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-05-28 for a 2026-05-26 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Lennox International Inc.

Company-level read

Ticker impact

$LIINeutralLow confidence
Context

Lennox International director Somasundaram Sivasankaran sold 343 shares to the issuer, per a newly filed SEC Form 4.

Expected impact

Likely limited near-term impact; any effect would be small and short-lived unless follow-on filings show sustained selling.

Evidence & confidence

The filing discloses an insider transaction but provides no sale price, no change in business outlook, and no stated reason; insider sales are common and often not predictive.

Market effects

No clear sector read-through from a single director sale to the issuer.

None indicated.

None indicated.

Counterpoint

The sale could be administrative (e.g., issuer buyback participation or liquidity need) and not a bearish signal, especially since the transaction is to the issuer.

Key entities

  • Lennox International Inc

    US-listed company whose director insider sale is disclosed on Form 4.

  • Somasundaram Sivasankaran

    Director who sold 343 shares to the issuer on 2026-05-26.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIIMed

Goldman Sachs downgrades Lennox stock rating on weak demand

Goldman Sachs downgraded Lennox International (LII) to Neutral from Buy, lowering its price target to $390 from $547 due to weak demand in residential HVAC and competitive pressure. LII stock is near its 52-week low, down 40% from its high. The firm cited earnings risk for 2027 and a slower-than-expected recovery in the residential HVAC market. LII reported mixed Q2 2026 results, beating earnings estimates but missing on revenue. The company revised its full-year profit outlook downward.

$LIIHigh

Lennox Declares Quarterly Dividend

Lennox (NYSE: LII) declared a quarterly cash dividend of $1.36 per share, payable October 15, 2026, to shareholders of record on September 30, 2026. The company is a leader in energy-efficient building solutions, serving residential and commercial customers.

$AMGNMed

As Fed hike looms, AI strategy’s mid-cap picks draw attention with 580% gain

U.S. 10-year Treasury yields hit 5%, highest since 2007, ahead of Fed decision with 90% chance of a 25-basis-point hike. Investing.com's Mid-Cap Movers strategy gained 580.7% since 2013, outperforming S&P MidCap 400. Top performers include Commvault (CVLT, +8.5%), Insight Enterprises (NSIT, +5.0%), and Wingstop (WING, +4.7%). Lennox International (LII) downgraded to Hold, Amgen (AMGN) FDA approval for Imdelltra.

$AAONMed

Q2 Earnings Highlights: A.O. Smith (NYSE:AOS) Vs The Rest Of The HVAC and Water Systems Stocks

AAON (NYSE:AOS) beat analyst estimates and reported fastest revenue growth among HVAC peers, but its stock is down 19.2%. Lennox (NYSE:LII) missed revenue expectations, with stock down 29.4%. Trane Technologies (NYSE:TT) and Zurn Elkay (NYSE:ZWS) both exceeded revenue estimates, but their stocks are down 1.5% and 7.7% respectively. Market focus has shifted from AI to geopolitics and back to fundamentals.

$LIIMed

Lennox (LII) Q2 2026 Earnings Call Transcript

Lennox (LII) Q2 2026 call said residential demand remains challenging, with revenue down 7% YoY due to a 12% unit-volume decline, partially offset by mix and pricing (+3%) and acquisitions (+2%). Building Climate Solutions revenue rose 24% (organic +12%). Management cut earnings outlook and expects recovery benefits into 2027; it reported 92% TTM free-cash conversion and repurchased about $130M shares.